Tvardi Therapeutics’ TTI-109 Phase 1 Study Confirms Prodrug Design, Improved Tolerability and Pharmacodynamic Evidence of STAT3 Target Engagement

TTI-109 delivered TTI-101-equivalent exposure with improved tolerability and meaningful reductions in disease-relevant STAT3-driven immune cell ...

Endogenex Announces Full Enrollment of the ReCET Clinical Study

Endogenex, a clinical-stage medical device company dedicated to improving outcomes in individuals with type 2 diabetes (T2D), announced that the ReCET Clinical Study has reached full enrollment. A ...
BMJ Open

Mental health outcomes and psychosocial correlates among adult members of business families in Germany (WIFU-GESUND): study protocol for a representative c…

Introduction Mental health is an urgent public health issue with social and economic relevance. Business families play a key ...